European Union regulators said Thursday that the Oxford-AstraZeneca COVID-19 vaccine is safe and not linked to an overall increase in the risk of blood clots, an announcement that corroborates safety claims made by the vaccine maker and other health agencies after about a dozen countries halted the vaccine’s administration over blood clot concerns.
The AstraZeneca vaccine, which has not been made available in the U.S., has been administered to 20 million people throughout Europe and has been heralded as an important tool for curbing the pandemic due to its relatively accessible refrigeration requirements. But administration of the vaccine was recently halted in more than a dozen mostly European countries following scattered reports that a small number of people who had received it later experienced blood clots, according to The Associated Press.
.png)
.png)
